Febuxostat and Vincristine sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Febuxostat and Vincristine sulfate. Common interactions include abdominal pain upper among females and azotaemia among males.

The phase IV clinical study analyzes what interactions people who take Febuxostat and Vincristine sulfate have. It is created by eHealthMe based on reports of 35 people who take Febuxostat and Vincristine sulfate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 03, 2022

35 people who take Febuxostat and Vincristine sulfate together, and have interactions are studied.


What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 5,998 Febuxostat users for its effectiveness, alternative drugs and more.

What is Vincristine sulfate?

Vincristine sulfate has active ingredients of vincristine sulfate. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 24,966 Vincristine sulfate users for its effectiveness, alternative drugs and more.

Number of Febuxostat and Vincristine sulfate reports submitted per year:

Febuxostat and Vincristine sulfate drug interactions.

Common Febuxostat and Vincristine Sulfate drug interactions by gender *:

female:

  1. Abdominal pain upper
  2. Dizziness
  3. Hepatic haemorrhage
  4. Malaise
  5. Tumour lysis syndrome
  6. Tumour rupture
  7. Atopy
  8. Bronchitis
  9. Erythema multiforme
  10. Pneumonia aspiration

male:

  1. Azotaemia
  2. Decreased appetite
  3. Acute myeloid leukaemia
  4. Cystitis haemorrhagic
  5. Hypogammaglobulinaemia
  6. Hypokalaemia
  7. Injection site pain
  8. Myelosuppression
  9. Sinobronchitis
  10. Antithrombin iii decreased

Common Febuxostat and Vincristine Sulfate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Antithrombin iii decreased
  2. Blood fibrinogen decreased
  3. Diarrhoea
  4. Haemorrhoids
  5. Headache
  6. Insomnia
  7. Bone marrow failure
  8. Febrile neutropenia
  9. Injection site pain
  10. Myelosuppression

40-49:

  1. Atopy
  2. Erythema multiforme
  3. Skin infection
  4. Stevens-johnson syndrome

50-59:

  1. Malaise
  2. Tumour lysis syndrome
  3. Tumour rupture
  4. Abdominal pain upper
  5. Dizziness
  6. Hepatic haemorrhage

60+:

  1. Azotaemia
  2. Decreased appetite
  3. Acute myeloid leukaemia
  4. Cystitis haemorrhagic
  5. Hypogammaglobulinaemia
  6. Hypokalaemia
  7. Sinobronchitis

Common conditions people have *:

  1. Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 18 people, 51.43%
  2. Constipation: 15 people, 42.86%
  3. Insomnia (sleeplessness): 13 people, 37.14%
  4. Fever: 11 people, 31.43%
  5. Infusion Related Reaction: 8 people, 22.86%
  6. Myelosuppression (a decrease in the production of blood cells): 8 people, 22.86%
  7. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 7 people, 20.00%
  8. High Blood Pressure: 7 people, 20.00%
  9. Nausea (feeling of having an urge to vomit): 6 people, 17.14%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 17.14%

* Approximation only. Some reports may have incomplete information.

Do you take Febuxostat and Vincristine sulfate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Febuxostat and Vincristine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Febuxostat interactions:

Browse all interactions between Febuxostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vincristine sulfate interactions:

Browse all interactions between Vincristine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat and vincristine sulfate (the active ingredients of Febuxostat and Vincristine sulfate, respectively), and Febuxostat and Vincristine sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Febuxostat and Vincristine sulfate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: